These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12702534)

  • 21. Pilot phase II study of gemcitabine and vinorelbine in patients with recurrent or refractory small cell lung cancer.
    Dudek AZ; Leśniewski-Kmak K; Bliss RL; Brunstein C; Condon DL; Kratzke RA
    Lung; 2005; 183(1):43-52. PubMed ID: 15793666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.
    Juergens R; Brahmer J; Ettinger D
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):621-9. PubMed ID: 16937106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: a phase II study.
    Lilenbaum R; Cano R; Schwartz M; Siegel L; Lutzky J; Lewis M; Krill E; Barreras L; Davila E
    Cancer; 2000 Feb; 88(3):557-62. PubMed ID: 10649247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group.
    Laack E; Dickgreber N; Müller T; Knuth A; Benk J; Lorenz C; Gieseler F; Dürk H; Engel-Riedel W; Dalhoff K; Kortsik C; Graeven U; Burk M; Dierlamm T; Welte T; Burkholder I; Edler L; Hossfeld DK;
    J Clin Oncol; 2004 Jun; 22(12):2348-56. PubMed ID: 15197195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trial.
    Dileo P; Morgan JA; Zahrieh D; Desai J; Salesi JM; Harmon DC; Quigley MT; Polson K; Demetri GD; George S
    Cancer; 2007 May; 109(9):1863-9. PubMed ID: 17385194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: a minnie pearl cancer research network phase II trial.
    Hainsworth JD; Burris HA; Litchy S; Erland JB; Hon JK; Brierre JE; Greco FA
    Cancer; 2000 Mar; 88(6):1353-8. PubMed ID: 10717616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer.
    Gennatas C; Michalaki V; Mouratidou D; Tsavaris N; Andreadis C; Psychogios J; Poulakaki N
    Anticancer Res; 2006; 26(1B):549-52. PubMed ID: 16739318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer.
    Isokangas OP; Knuuttila A; Halme M; Mäntylä M; Lindström I; Nikkanen V; Viren M; Joensuu H; Mattson K
    Ann Oncol; 1999 Sep; 10(9):1059-63. PubMed ID: 10572603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10.
    Hong SH; Lee S; Kim HG; Lee HJ; Jung KH; Lee SC; Lee NR; Yun J; Woo IS; Park KH; Kim KH; Kim HY; Rha SY; Byun JH
    Gynecol Oncol; 2015 Feb; 136(2):212-7. PubMed ID: 25462205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trial.
    Gioulbasanis I; Saridaki Z; Kalykaki A; Vamvakas L; Kalbakis K; Ignatiadis M; Amarantidis K; Kakolyris S; Georgoulias V; Mavroudis D
    Anticancer Res; 2008; 28(5B):3019-25. PubMed ID: 19031950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.
    Gebbia V; Galetta D; Caruso M; Verderame F; Pezzella G; Valdesi M; Borsellino N; Pandolfo G; Durini E; Rinaldi M; Loizzi M; Gebbia N; Valenza R; Tirrito ML; Varvara F; Colucci G;
    Lung Cancer; 2003 Feb; 39(2):179-89. PubMed ID: 12581571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of vinorelbine plus gemcitabine as third-line chemotherapy for refractory non-small cell lung cancer.
    Ando S; Suzuki M; Iida T; Nakajima T; Kimura H
    Oncol Rep; 2005 Sep; 14(3):689-94. PubMed ID: 16077976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I study.
    Frasci G; Panza N; Comella P; Nicolella GP; Natale M; Pacilio C; Gravina A; Caputi V; Botti G; Comella G
    Ann Oncol; 1997 Oct; 8(10):1045-8. PubMed ID: 9402180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase I study of an all-oral combination of vinorelbine/capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and/or taxanes.
    Kellokumpu-Lehtinen PL; Sunela K; Lehtinen I; Joensuu H; Sjöström-Mattson J;
    Clin Breast Cancer; 2006 Dec; 7(5):401-5. PubMed ID: 17239265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trial.
    Bajetta E; Chiara Stani S; De Candis D; Bidoli P; Mariani L; Zilembo N; Pozzi P; Procopio G
    Cancer; 2000 Aug; 89(4):763-8. PubMed ID: 10951338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
    Pectasides D; Kalofonos HP; Samantas E; Nicolaides C; Papacostas P; Onyenadum A; Visvikis A; Skarlos D; Fountzilas G
    Anticancer Res; 2001; 21(4B):3005-10. PubMed ID: 11712802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer.
    Han JY; Lee DH; Song JE; Lee SY; Kim HY; Kim HT; Lee JS
    Cancer; 2008 Jul; 113(2):388-95. PubMed ID: 18484595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer.
    Lorusso V; Carpagnano F; Frasci G; Panza N; Di Rienzo G; Cisternino ML; Napoli G; Orlando S; Cinieri S; Brunetti C; Palazzo S; De Lena M
    J Clin Oncol; 2000 Jan; 18(2):405-11. PubMed ID: 10637256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot trial of gemcitabine and vinorelbine plus capecitabine in locally advanced or metastatic nonsmall cell lung cancer.
    Lee DH; Han JY; Yoon SM; Lee JJ; Lee HG; Kim HY; Yoon SJ; Hong EK; Lee JS
    Am J Clin Oncol; 2006 Apr; 29(2):143-7. PubMed ID: 16601432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancer.
    Esteban E; Fra J; Corral N; Valle M; Carrasco J; Sala M; Puerta J; Estrada E; Palacio I; Vieitez JM; Buesa JM; Lacave AJ
    Invest New Drugs; 2002 Feb; 20(1):73-82. PubMed ID: 12003196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.